Obesity-Related Metabolic Syndrome: Mechanisms of Sympathetic Overactivity

Role of leptin and central nervous system melanocortins in obesity hypertension

(2013) Alexandre A. da Silva et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Leptin Acts in the Forebrain to Differentially Influence Baroreflex Control of Lumbar, Renal, and Splanchnic Sympathetic Nerve Activity and Heart Rate

(2013) Baoxin Li et al.   HYPERTENSION

Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease

(2013) Markus P. Schlaich et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Leptin Stimulates Both Endothelin-1 and Nitric Oxide Activity in Lean Subjects But Not in Patients With Obesity-Related Metabolic Syndrome

(2013) Francesca Schinzari et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Dysregulation of the Autonomic Nervous System Predicts the Development of the Metabolic Syndrome

(2013) Carmilla M. M. Licht et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Sympathetic support of energy expenditure and sympathetic nervous system activity after gastric bypass surgery

(2013) Timothy B. Curry et al.   Obesity

Chronic central ghrelin infusion reduces blood pressure and heart rate despite increasing appetite and promoting weight gain in normotensive and hypertensive rats

(2013) John N. Freeman et al.   PEPTIDES

Leptin in nucleus of the solitary tract alters the cardiovascular responses to aortic baroreceptor activation

(2013) John Ciriello   PEPTIDES

Sympathetic Nervous System Function and Dysfunction in Chronic Hemodialysis Patients

(2013) Dvora Rubinger et al.   SEMINARS IN DIALYSIS

Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome

(2012) Francesca Schinzari et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Diabetes and Hypertension: Is There a Common Metabolic Pathway?

(2012) Bernard M. Y. Cheung et al.   Current Atherosclerosis Reports

Neuroadrenergic Dysfunction Along the Diabetes Continuum: A Comparative Study in Obese Metabolic Syndrome Subjects

(2012) N. E. Straznicky et al.   DIABETES

Renal Denervation in a Hypertensive Patient With End-Stage Renal Disease and Small Arteries: A Direction for Future Research

(2012) Christian Ott et al.   Journal of Clinical Hypertension

Obesity and adipokines: effects on sympathetic overactivity

(2012) Michael M. Smith et al.   JOURNAL OF PHYSIOLOGY-LONDON

Renal sympathetic nerve ablation for the treatment of difficult-to-control or refractory hypertension in a haemodialysis patient

(2012) N. Di Daniele et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension

(2012) Tom Mabin et al.   EuroIntervention

Leptin increasing sympathetic nerve outflow in obesity

(2012) Stephanie E. Simonds et al.   Adipocyte

Obesity, blood vessels and metabolic syndrome

(2011) M. Tesauro et al.   Acta Physiologica

Regulation of vascular tone by adipocytes

(2011) Nele Maenhaut et al.   BMC Medicine

Human obesity and endothelium-dependent responsiveness

(2011) Umberto Campia et al.   BRITISH JOURNAL OF PHARMACOLOGY

Calorie Restriction inhibits Sympathetic Nerve Activity via Anti-Oxidant Effect in the Rostral Ventrolateral Medulla of Obesity-Induced Hypertensive Rats

(2011) Takuya Kishi et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Sympatho-renal axis in chronic disease

(2011) Paul A. Sobotka et al.   Clinical Research in Cardiology

Ghrelin Modulates Sympathetic Nervous System Activity and Stress Response in Lean and Overweight Men

(2011) Elisabeth Lambert et al.   HYPERTENSION

Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications

(2011) Graziela Z Kalil et al.   HYPERTENSION RESEARCH

Renal denervation: a potential new treatment modality for polycystic ovary syndrome?

(2011) Markus P Schlaich et al.   JOURNAL OF HYPERTENSION

Insulin acts in the arcuate nucleus to increase lumbar sympathetic nerve activity and baroreflex function in rats

(2011) Priscila A. Cassaglia et al.   JOURNAL OF PHYSIOLOGY-LONDON

Arcuate nucleus - a gateway for insulin's action on sympathetic activity

(2011) R. A. L. Dampney   JOURNAL OF PHYSIOLOGY-LONDON

ADIPOQ, ADIPOR1, and ADIPOR2 Polymorphisms in Relation to Serum Adiponectin Levels and BMI in Black and White Women

(2011) Sarah S. Cohen et al.   Obesity

Change in sympathetic nerve firing pattern associated with dietary weight loss in the metabolic syndrome

(2011) Elisabeth Lambert   Frontiers in Physiology

Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome

(2010) Francesca Schinzari et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Resistant Hypertension in the High-Risk Metabolic Patient

(2010) Kunal Chaudhary et al.   Current Diabetes Reports

Sympathetic Nervous System Activity Is Associated With Obesity-Induced Subclinical Organ Damage in Young Adults

(2010) Elisabeth Lambert et al.   HYPERTENSION

Obesity-induced Hypertension: Role of Sympathetic Nervous System, Leptin, and Melanocortins

(2010) John E. Hall et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Effects of Weight LossVersusWeight Loss Maintenance on Sympathetic Nervous System Activity and Metabolic Syndrome Components

(2010) Nora E. Straznicky et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Hypertension, Dyslipidemia, and Insulin Resistance in Patients With Diabetes Mellitus or the Cardiometabolic Syndrome: Benefits of Vasodilating β-Blockers

(2010) Prakash Deedwania   Journal of Clinical Hypertension

Insulin enhances the gain of arterial baroreflex control of muscle sympathetic nerve activity in humans

(2010) Colin N. Young et al.   JOURNAL OF PHYSIOLOGY-LONDON

The arcuate nucleus as a circumventricular organ in the mouse

(2010) Philippe Ciofi   NEUROSCIENCE LETTERS

Sympathetic nervous activation in obesity and the metabolic syndrome—Causes, consequences and therapeutic implications

(2010) Gavin W. Lambert et al.   PHARMACOLOGY & THERAPEUTICS

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Non-esterified fatty acids increase arterial pressure via central sympathetic activation in humans

(2009) John P. Florian et al.   CLINICAL SCIENCE

Ghrelin Restores the Endothelin 1/Nitric Oxide Balance in Patients With Obesity-Related Metabolic Syndrome

(2009) Manfredi Tesauro et al.   HYPERTENSION

Pathogenesis and Pathophysiology of the Cardiometabolic Syndrome

(2009) Erik P. Kirk et al.   Journal of Clinical Hypertension

Adiponectin: from obesity to cardiovascular disease

(2009) C. Antoniades et al.   Obesity Reviews

Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome

(2008) Nora E Straznicky et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Metabolic Syndrome Pandemic

(2008) Scott M. Grundy   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk

(2008) Jean-Pierre Després et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The link between abdominal obesity and the metabolic syndrome

(2008) Liza K. Phillips et al.   CURRENT HYPERTENSION REPORTS

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases

(2008) G. R. Hajer et al.   EUROPEAN HEART JOURNAL

High-Circulating Leptin Levels Are Associated with Greater Risk of Hypertension in Men Independently of Body Mass and Insulin Resistance: Results of an Eight-Year Follow-Up Study

(2008) F. Galletti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Increased oxidative stress precedes the onset of high-fat diet–induced insulin resistance and obesity

(2008) Naoto Matsuzawa-Nagata et al.   METABOLISM-CLINICAL AND EXPERIMENTAL